Results for this period
Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in Millions of yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue increased due to the continued rollout of new and improved products and strengthened sales activities in Japan, improvements to existing products in Europe, the acquisition of new customers in the United States, and strong performance in Asian countries. Operating profit increased due to higher revenue, while ordinary profit increased due to the recognition of subsidy income and the absence of listing-related expenses incurred in the same period of the previous year.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026–30 September 2026 |
| Net Sales | 6,006 Millions of yen (YoY +14.5%) |
| Operating profit | 3,014 Millions of yen (YoY +8.8%) |
| Ordinary income | 3,098 Millions of yen (YoY +13.5%) |
| Profit attributable to owners of the parent | 2,027 Millions of yen (YoY +12.3%) |
| Net income per share | ¥50.69 |
| Equity ratio | End of the current fiscal period 92.6 / End of previous period 93.2 |
| Total assets | 22,553 Millions of yen |
| Net assets | 20,892 Millions of yen |
| Cash flows from operating activities | 2,329 Millions of yen |
| Cash flows from investing activities | -34 Millions of yen |
| Cash flows from financing activities | -1,660 Millions of yen |
| Cash and cash equivalents at end of period | 14,042 Millions of yen |
| Full-year earnings forecast | Net Sales 11,346 Millions of yen (YoY +3.6%) / Operating profit 6,115 Millions of yen (YoY +4.4%) / Ordinary income 6,137 Millions of yen (YoY +4.0%) / Net income 4,059 Millions of yen (YoY +4.2%) |
| Annual Dividend Forecast | 41 Yen → 41 Yen（0.0%） |
| Segment revenue | Omitted because the Company operates in a single segment, the medical equipment business. |
| Segment profit | Omitted because the Company operates in a single segment, the medical equipment business. |
| Regional sales | Japan 1,939 Millions of yen (YoY +7.7%) / Overseas expansion 4,067 Millions of yen (YoY +18.0%) / Europe 2,300 Millions of yen (YoY +19.5%) / United States 606 Millions of yen (YoY +10.2%) / China 323 Millions of yen (YoY +17.3%) / India 249 Millions of yen (YoY -19.7%) / Other 588 Millions of yen (YoY +52.3%) |
| Depreciation and amortization | 111 Millions of yen |
| Impairment loss | No amount or affected assets were disclosed for the interim period. |
| Breakdown of extraordinary income (loss) | For the interim period, extraordinary income was "-"; no extraordinary loss was reported. |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | None (no company names were disclosed for additions or exclusions). |
| Availability of Supplementary Financial Results Materials | Available |
| Availability of Financial Results Briefing | Yes (for institutional investors and analysts) |
| Issued Shares at Period-End | 40,000,000 shares |
| Treasury Shares at Period-End | 0 shares |
| Factors Behind Changes in Business Performance | Revenue increased due to the continued rollout of new and improved products and strengthened sales activities in Japan, improvements to existing products in Europe, the acquisition of new customers in the United States, and strong performance in Asian countries. Operating profit increased due to higher revenue, while ordinary profit increased due to the recognition of subsidy income and the absence of listing-related expenses incurred in the same period of the previous year. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In Japan, continued rollout of new and improved products and strengthened sales activities contributed to higher revenue. Overseas, revenue was supported by improvements to existing products in Europe, the acquisition of new customers in the United States, and strong performance in Asian countries. The reasons for the increase in profit included higher revenue, the recognition of subsidy income, and the absence of listing-related expenses incurred in the same period of the previous year.